4//SEC Filing
Maloberti Renaud Bertrand 4
Accession 0001209191-21-025850
CIK 0001681682other
Filed
Apr 6, 8:00 PM ET
Accepted
Apr 7, 4:11 PM ET
Size
5.4 KB
Accession
0001209191-21-025850
Insider Transaction Report
Form 4
Maloberti Renaud Bertrand
Chief Commercial Officer
Transactions
- Award
Stock Options
2021-04-05+25,000→ 25,000 totalExercise: $2.64Exp: 2031-04-05→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]This stock option grant becomes exercisable in three equal annual installments beginning April 5, 2022.
Documents
Issuer
ENDRA Life Sciences Inc.
CIK 0001681682
Entity typeother
Related Parties
1- filerCIK 0001744025
Filing Metadata
- Form type
- 4
- Filed
- Apr 6, 8:00 PM ET
- Accepted
- Apr 7, 4:11 PM ET
- Size
- 5.4 KB